Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| kit | 2 |
| Route | NDCs |
|---|---|
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| r-pharm us operating, llc | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| IXEMPRA | ixabepilone | kit | 70020-1910NDA |
| IXEMPRA | ixabepilone | kit, intravenous | 70020-1911NDA |
Enquiry
Common questions
- Is R-Pharm US Operating, LLC FDA approved?
- R-Pharm US Operating, LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does R-Pharm US Operating, LLC make?
- 2 products are listed under R-Pharm US Operating, LLC in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.